Objective: To evaluate associations between insurance status and HPV vaccination.
| INTRODUCTION
HPV comprises a group of more than 150 related viruses.
1 Depending on the strain, HPV can cause cervical, vaginal, and vulvar cancers among women; penile cancer among men; and anal cancer, cancer of the oropharynx, and genital warts among both men and women. 2 The infection spreads via skin-to-skin contact, or through vaginal, anal, or oral sex with an infected individual. An important preventative method that has been offered since June 2006 is the HPV vaccine. 3 A full vaccine series of three shots is recommended for most sexually active individuals up to 26 years of age, and it protects against four more prevalent strains: HPV6, HPV11, HPV16, and HPV18. 2, 4 The prevalence of HPV infection has significantly decreased since the HPV vaccine was introduced. 5 Although the vaccine is available to the general public, acceptance and utilization have been much lower than the recommendations of the Advisory Committee for Immunization Practices. 6 Therefore, it is essential to identify and address factors associated with utilization of the HPV vaccine in order to improve the national vaccination rate and reduce the risk of HPV infection.
Strong provider recommendation may facilitate HPV vaccination ,5 but barriers to utilization include lack of provider recommendation, negative parent or patient attitudes and beliefs, costs, and missed clinical opportunities. 6 One study has suggested that insurance status may play a large role in whether or not individuals receive the HPV vaccine. 7 Others have focused on broad factors at the individual and provider level that influence the acceptability, initiation, and receipt of HPV vaccination among different racial and ethnic groups. [8] [9] [10] [11] [12] [13] However, those studies have limitations, and none of them examined the potential role of race/ethnicity in moderating the relationship between insurance status and receipt of HPV vaccine.
To our knowledge, evidence quantifying the moderating role of individual characteristics on the relationship between insurance statuses and receipt of HPV vaccination is currently lacking. The aim of the present study was therefore to investigate the moderating role of race/ethnicity on the relationship between insurance receipts of HPV vaccination in a nationally representative sample of adults in the USA.
| MATERIALS AND METHODS
The present cross-sectional study analyzed data merged from the NHANES has been administered in 2-year cycles by the National
Center for Health Statistics to assess the health and nutritional status of adults and children in the United States. The methodology applied in data collection including the questionnaire has been described in detail elsewhere. 3 In brief, participants in NHANES are selected by using multistage probability sampling and are representative of the non-institutionalized civilian population in the USA. The main outcome of interest was receipt of HPV vaccine. In NHANES, participants were given the following information and asked whether they had received the HPV vaccine: "Human papillomavirus vaccine is given to prevent cervical cancer in girls and women. It is given in three separate doses over 6 months and has been recommended for girls and women since June 2006. Have you ever received one or more doses of the HPV vaccine?" The response options included "yes," "no,"
"refused," and "don't know." For the present analysis, the variable was dichotomized as "yes" or "no." Participants were excluded from the analysis if they responded "refused" or "don't know."
Participants were also asked whether they were covered by insur- is "excellent," "very good," "good," "fair," or "poor." These five choices were then recoded to reflect three categories: "excellent/very good," "good," and "fair/poor."
Statistical analysis was performed by using SAS version 9.4 (SAS Institute, Cary, NC, USA). Descriptive statistics were used to describe and summarize the data. As recommended, 3 sample weights accounting for the unequal probabilities of selection, oversampling, and nonresponse in NHANES were applied to all analyses. Bivariate analysis using the χ 2 test was used to compare women with and without HPV vaccination by insurance, type of insurance, race, and all other potential confounders. Each covariate was retained in the multivariable model irrespective of the P value in the bivariate analysis.
Logistic regression analysis was performed to determine associations between insurance status and HPV vaccination. Pairwise comparisons between insurance status, type of insurance, and race/ ethnicity were examined to test whether the relationships among insurance, type of insurance, and HPV vaccine utilization differed by race/ethnicity. Odds ratios (ORs), 95% confidence intervals (95% CIs),
and P values were reported. Potential multicollinearity was assessed via tolerance and the variance inflation factor, which showed that the regression analysis was not prone to multicollinearity. P<0.05 was considered statistically significant.
| RESULTS
The present study sample consisted of 1026 women aged 18-26 years.
After excluding those with data missing for HPV vaccination status, insurance, or any of the covariates assessed (n=405), 621 participants were included in the analysis. The characteristics of the study sample stratified by receipt of HPV vaccine are presented in Table 2 . The incidence of HPV vaccination was higher among women who were insured than among those who were uninsured (P=0.015). Other characteristics that showed a significant difference in the receipt of HPV vaccination included age, education, number of individuals in family, family income to poverty ratio, and general health condition.
In the multivariable model, race/ethnicity was observed to have a significant effect on the association between insurance status and receipt of HPV vaccine (Table 3) . After adjusting for demographic, Values are given as number (weighted percentage) or mean ± SE unless indicated otherwise. Weighted percentages were obtained to control for the complex sample design; therefore, division of individual cell sizes by the total sample does not reflect the percentages shown. 
T A B L E 3 Association between insurance status and receipt of HPV vaccine (n=621).

| DISCUSSION
The principal finding of the current study was that race/ethnicity had a significant effect on the association between insurance status and receipt of HPV vaccine. The observed association was independent of age, education, and general health condition, history of STD/STI, number of individuals in household, number of days physical health was not good, and ratio of family income to poverty.
Our present findings are consistent with previous research studies that identified an independent association between insurance status, race/ethnicity, and HPV vaccination. [14] [15] [16] One study identified lack of insurance as a major barrier to HPV vaccination owing to the high cost associated with the vaccine series. 16 This is concerning because women with no insurance also have low utilization of cervical cancer screening and are therefore at risk of invasive cervical cancer.
17
In the current study, non-Hispanic black women with no insurance were less likely to receive HPV vaccine as compared with those who had some type of insurance. This finding may partly explain the higher rates of HPV infection among non-Hispanic black women as compared with all other races/ethnicities. 18 Several studies previously reported that, even when the HPV vaccine was made available, non-Hispanic blacks were less likely to initiate the vaccination series or to complete vaccination as compared with other races/ethnicities. 16, 19, 20 However, a more recent study demonstrated that a higher proportion of nonHispanic black adolescents received at least one dose of HPV vaccine relative to their white counterparts.
21
One plausible explanation for the observed association between insurance status and receipt of HPV vaccine would be the introduction of the Affordable Care Act that has enabled many who were previously without insurance to become insured. In this case, many nonHispanic black women who had previously been uninsured may have been able to obtain insurance and thus able to afford HPV vaccination.
The present lack of a significant association between insurance status and receipt of HPV vaccine among non-Hispanic white women might reflect the fact that lack of health insurance coverage was more common among African American than among white individuals before implementation of the Affordable Care Act in 2010. 22 Thus, among the non-Hispanic white population, where insurance status had not previously been as much of a barrier to HPV vaccination, other factors such as attitudes and beliefs towards vaccination might play a stronger role in the decision to receive the HPV vaccine. Further research is needed to understand these differences.
A negative association between insurance status and vaccination was observed among Mexican Americans. Lack of preventive-care seeking behavior due to the expense, even with an insurance plan, might be a possible explanation for the negative association observed. Mexican
Americans have been reported to delay seeking care until the severity of the condition requires emergency attention. 23 Moreover, concerns about immigration status discovery might be a factor in the reason why the Mexican American population avoids health care in the United States.
23
In the current study, older women were less likely to receive HPV vaccine as compared with younger women. This might be because the HPV vaccine was relatively new during the period of data collection and was targeted toward younger adolescents at that time. There was also a positive association between education level and HPV vaccination. Women with education beyond high school were more likely to receive the HPV vaccine as compared with those with education below high school. This result might be expected because it is generally common for those with higher education to be more aware of available healthcare options.
The study has some limitations. First, some questions in the NHANES questionnaire were restricted to specific groups of individuals based on age, which reduced the study sample. Second, men were excluded from the study because only a few males had responded to the question on HPV vaccination status. Nevertheless, the analysis showed that participants who were excluded due to missing data were in general similar to the final analytic sample ( Table 5 ), suggesting that the findings are generalizable to the target population. Third, questions related to participant knowledge, attitudes, or beliefs about HPV vaccination, which are known to play a role in receipt of HPV vaccine, were not examined because they were not captured in NHANES. Last, the cross-sectional nature of the study precludes causal inference. A strength of the current study is that it was based on a relatively large nationally representative sample collected via a pretested and previously validated questionnaire.
In addition, the availability of several variables in the dataset enabled the model to control for potential confounders.
In conclusion, in a nationally representative sample of women aged 18-26 years in the USA, race/ethnicity was found to moderate the association between insurance status and receipt of HPV vaccine.
The observed association was independent of potential confounders. Future studies should examine the potential role of attitudes and beliefs toward the HPV vaccine, while examining the role of insurance status on receipt of the vaccine. The present findings are important for minority race/ethnic groups who have insurance coverage but are at risk for negative health outcomes.
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Comparison of the final analytic sample to those who were excluded due to missing data. 
